{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:38:49Z","timestamp":1793741929237,"version":"4.6.1"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-025-02015-w","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T14:38:45Z","timestamp":1764167925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Lean type 2 diabetes: the overlooked epidemic reshaping global health"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9879-1087","authenticated-orcid":false,"given":"Vinay","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"1","key":"2015_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jn\/134.1.205","volume":"134","author":"CS Yajnik","year":"2004","unstructured":"Yajnik CS. Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries. J Nutr. 2004;134(1):205\u201310. https:\/\/doi.org\/10.1093\/jn\/134.1.205.","journal-title":"J Nutr"},{"key":"2015_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/nyas.12098","volume":"1281","author":"RCW Ma","year":"2013","unstructured":"Ma RCW, Chan JCN. Type 2 diabetes in East asians: similarities and differences with populations in Europe and the united States. Ann N Y Acad Sci. 2013;1281:64\u201391. https:\/\/doi.org\/10.1111\/nyas.12098.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"2015_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist E, Storm P, K\u00e4r\u00e4j\u00e4m\u00e4ki A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6(5):361\u20139. https:\/\/doi.org\/10.1016\/S2213-8587(18)30051-2.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2015_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/genes6010087","volume":"6","author":"RB Prasad","year":"2015","unstructured":"Prasad RB, Groop L. Genetics of type 2 diabetes\u2013pitfalls and possibilities. Genes. 2015;6(1):87\u2013123. https:\/\/doi.org\/10.3390\/genes6010087.","journal-title":"Genes"},{"issue":"2","key":"2015_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/ijo.2010.135","volume":"35","author":"A Misra","year":"2011","unstructured":"Misra A, Khurana L. Obesity-related non-communicable diseases: South Asians vs white Caucasians. Int J Obes. 2011;35(2):167\u201387. https:\/\/doi.org\/10.1038\/ijo.2010.135.","journal-title":"Int J Obes"},{"issue":"9733","key":"2015_CR6","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/S0140-6736(10)60550-8","volume":"375","author":"JC Mbanya","year":"2010","unstructured":"Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in sub-Saharan Africa. Lancet. 2010;375(9733):2254\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(10)60550-8.","journal-title":"Lancet"},{"issue":"1","key":"2015_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/ije\/31.1.234","volume":"31","author":"A Hennis","year":"2002","unstructured":"Hennis A, Wu SY, Nemesure B, Li X, Leske MC. Diabetes in a Caribbean population: epidemiological profile and implications. Int J Epidemiol. 2002;31(1):234\u20139. https:\/\/doi.org\/10.1093\/ije\/31.1.234.","journal-title":"Int J Epidemiol"},{"issue":"9403","key":"2015_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO Expert Consultation","year":"2004","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(03)15268-3.","journal-title":"Lancet"},{"issue":"7","key":"2015_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S2213-8587(21)00088-7","volume":"9","author":"R Caleyachetty","year":"2021","unstructured":"Caleyachetty R, Thomopoulos C, Tait CA, et al. Ethnicity-specific BMI thresholds for screening and intervention in minority populations: a population-based cohort study in England. Lancet Diabetes Endocrinol. 2021;9(7):419\u201326. https:\/\/doi.org\/10.1016\/S2213-8587(21)00088-7.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10296","key":"2015_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0140-6736(21)00844-8","volume":"398","author":"F Teufel","year":"2021","unstructured":"Teufel F, Seiglie JA, Geldsetzer P, Theilmann M, Marcus ME, Ebert C, et al. Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685\u2008616 adults. Lancet. 2021;398(10296):238\u201348. https:\/\/doi.org\/10.1016\/S0140-6736(21)00844-8.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"2015_CR11","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2337\/dc25-Sint","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee. Standards of care in Diabetes\u20142025. Diabetes Care. 2025;48(Suppl 1):S1\u2013321. https:\/\/doi.org\/10.2337\/dc25-Sint.","journal-title":"Diabetes Care"},{"issue":"11","key":"2015_CR12","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.2337\/dci22-0034","volume":"45","author":"MJ Davies","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the ADA and the EASD. Diabetes Care. 2022;45(11):2753\u201386. https:\/\/doi.org\/10.2337\/dci22-0034.","journal-title":"Diabetes Care"},{"issue":"5","key":"2015_CR13","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/jdi.13017","volume":"10","author":"R Nishimura","year":"2019","unstructured":"Nishimura R, Kanda A, Sano H, Matsudaira T, Morimoto A, Tajima N. Glycemic control and medication use in lean vs. obese Japanese patients with type 2 diabetes. J Diabetes Investig. 2019;10(5):1225\u201333. https:\/\/doi.org\/10.1111\/jdi.13017.","journal-title":"J Diabetes Investig"},{"issue":"20","key":"2015_CR14","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1001\/jama.2009.726","volume":"301","author":"JC Chan","year":"2009","unstructured":"Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129\u201340. https:\/\/doi.org\/10.1001\/jama.2009.726.","journal-title":"JAMA"},{"issue":"3","key":"2015_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1046\/j.1467-789X.2003.00105.x","volume":"4","author":"PT Katzmarzyk","year":"2003","unstructured":"Katzmarzyk PT, Bray GA. Ethnic differences in the relation between obesity and diabetes risk. Obes Rev. 2003;4(3):133\u20138. https:\/\/doi.org\/10.1046\/j.1467-789X.2003.00105.x.","journal-title":"Obes Rev"},{"issue":"12","key":"2015_CR16","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/sj.ijo.0800522","volume":"21","author":"EC Rush","year":"1997","unstructured":"Rush EC, Plank LD, Laulu MS, Robinson SM, Parnell WR, Beaglehole R. Body size, body composition, and fat distribution: a comparison of Pacific Islands and new Zealand Europeans. Int J Obes Relat Metab Disord. 1997;21(12):1124\u201331. https:\/\/doi.org\/10.1038\/sj.ijo.0800522.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"3","key":"2015_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.diabres.2004.01.014","volume":"65","author":"A Ramachandran","year":"2004","unstructured":"Ramachandran A, Snehalatha C, Vijay V. Low risk threshold for acquired diabetogenic factors in Asian Indians. Diabetes Res Clin Pract. 2004;65(3):189\u201395. https:\/\/doi.org\/10.1016\/j.diabres.2004.01.014.","journal-title":"Diabetes Res Clin Pract"},{"key":"2015_CR18","first-page":"759","volume":"53","author":"V Mohan","year":"2005","unstructured":"Mohan V, Deepa R, Deepa M, Somannavar S, Datta M. A simplified Indian diabetes risk score for screening for undiagnosed diabetic subjects. J Assoc Physicians India. 2005;53:759\u201363.","journal-title":"J Assoc Physicians India"},{"issue":"9548","key":"2015_CR19","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/S0140-6736(06)69703-1","volume":"368","author":"KH Yoon","year":"2006","unstructured":"Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368(9548):1681\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(06)69703-1.","journal-title":"Lancet"},{"issue":"12","key":"2015_CR20","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1007\/s00125-011-2291-5","volume":"54","author":"RM Anjana","year":"2011","unstructured":"Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et al. Prevalence of diabetes and prediabetes in urban and rural india: phase I results of the ICMR\u2013INDIAB study. Diabetologia. 2011;54(12):3022\u20137. https:\/\/doi.org\/10.1007\/s00125-011-2291-5.","journal-title":"Diabetologia"},{"issue":"1","key":"2015_CR21","first-page":"5","volume":"28","author":"E Sobngwi","year":"2002","unstructured":"Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans. Part 2: Ketosis-prone atypical diabetes mellitus. Diabetes Metab. 2002;28(1):5\u201312.","journal-title":"Diabetes Metab"},{"key":"2015_CR22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/dmrr.2652","volume":"31","author":"EV Balti","year":"2015","unstructured":"Balti EV, Kengne AP, Sobngwi E, et al. Ketosis-prone type 2 diabetes in sub-Saharan africans: clinical and metabolic characteristics. Diabetes Metab Res Rev. 2015;31:713\u201321. https:\/\/doi.org\/10.1002\/dmrr.2652.","journal-title":"Diabetes Metab Res Rev"},{"issue":"10","key":"2015_CR23","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.2337\/diacare.25.10.1648","volume":"25","author":"AJ Hennis","year":"2002","unstructured":"Hennis AJ, Wu SY, Nemesure B, Leske MC, Barbados Eye Studies Group. Diabetes in a Caribbean population: prevalence and associated risk factors. Diabetes Care. 2002;25(10):1648\u201353. https:\/\/doi.org\/10.2337\/diacare.25.10.1648.","journal-title":"Diabetes Care"},{"issue":"3","key":"2015_CR24","first-page":"259","volume":"59","author":"TS Ferguson","year":"2010","unstructured":"Ferguson TS, Tulloch-Reid MK, Wilks RJ. The epidemiology of diabetes mellitus in Jamaica and the Caribbean: a historical review. West Indian Med J. 2010;59(3):259\u201364.","journal-title":"West Indian Med J"},{"issue":"10","key":"2015_CR25","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1046\/j.1464-5491.1999.00143.x","volume":"16","author":"MC Gulliford","year":"1999","unstructured":"Gulliford MC, Mahabir D. Diabetes in trinidad: prevalence and associated factors. Diabet Med. 1999;16(10):875\u201380. https:\/\/doi.org\/10.1046\/j.1464-5491.1999.00143.x.","journal-title":"Diabet Med"},{"issue":"10","key":"2015_CR26","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1046\/j.1464-5491.1999.00143.x","volume":"16","author":"N Unwin","year":"1999","unstructured":"Unwin N, Alberti KG, Bennett N, McLarty D, Tuomilehto J, Wilks R. Diabetes in the caribbean: results of a population survey from Jamaica. Diabet Med. 1999;16(10):875\u201380. https:\/\/doi.org\/10.1046\/j.1464-5491.1999.00143.x.","journal-title":"Diabet Med"},{"issue":"11","key":"2015_CR27","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.2337\/diacare.24.11.1917","volume":"24","author":"HC Looker","year":"2001","unstructured":"Looker HC, Knowler WC, Hanson RL. Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care. 2001;24(11):1917\u201322. https:\/\/doi.org\/10.2337\/diacare.24.11.1917.","journal-title":"Diabetes Care"},{"issue":"7","key":"2015_CR28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.7326\/0003-4819-122-7-199504010-00001","volume":"122","author":"GA Colditz","year":"1995","unstructured":"Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122(7):481\u20136. https:\/\/doi.org\/10.7326\/0003-4819-122-7-199504010-00001.","journal-title":"Ann Intern Med"},{"issue":"9","key":"2015_CR29","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/j.1464-5491.1990.tb01473.x","volume":"7","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1990","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Characteristics of newly presenting type 2 diabetic patients: analysis of 4,031 patients in the UKPDS. Diabet Med. 1990;7(9):706\u201312. https:\/\/doi.org\/10.1111\/j.1464-5491.1990.tb01473.x.","journal-title":"Diabet Med"},{"issue":"3","key":"2015_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ng1732","volume":"38","author":"SF Grant","year":"2006","unstructured":"Grant SF, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38(3):320\u20133. https:\/\/doi.org\/10.1038\/ng1732.","journal-title":"Nat Genet"},{"issue":"9712","key":"2015_CR31","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S0140-6736(09)60937-5","volume":"375","author":"A Ramachandran","year":"2010","unstructured":"Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet. 2010;375(9712):408\u201318. https:\/\/doi.org\/10.1016\/S0140-6736(09)60937-5.","journal-title":"Lancet"},{"issue":"9","key":"2015_CR32","first-page":"795","volume":"20","author":"AM Hodge","year":"1996","unstructured":"Hodge AM, Dowse GK, Collins VR, Zimmet PZ. Abnormal glucose tolerance and diabetes in the Pacific: relation to body mass index and obesity. Int J Obes Relat Metab Disord. 1996;20(9):795\u2013800.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"1","key":"2015_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S2213-8587(13)70112-8","volume":"2","author":"PZ Zimmet","year":"2014","unstructured":"Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2014;2(1):56\u201364. https:\/\/doi.org\/10.1016\/S2213-8587(13)70112-8.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2015_CR34","doi-asserted-by":"publisher","first-page":"e14459","DOI":"10.1111\/dme.14459","volume":"38","author":"SA Balcha","year":"2021","unstructured":"Balcha SA, Phillips DIW. Insulin requirement in ketosis-prone diabetes: a systematic review and meta-analysis. Diabet Med. 2021;38(3):e14459. https:\/\/doi.org\/10.1111\/dme.14459.","journal-title":"Diabet Med"},{"issue":"3","key":"2015_CR35","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1210\/er.2007-0026","volume":"29","author":"A Balasubramanyam","year":"2008","unstructured":"Balasubramanyam A, Nalini R, Hampe CS, Maldonado M. Syndromes of ketosis-prone diabetes mellitus. Endocr Rev. 2008;29(3):292\u2013302. https:\/\/doi.org\/10.1210\/er.2007-0026.","journal-title":"Endocr Rev"},{"issue":"7","key":"2015_CR36","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.2337\/diacare.25.7.1191","volume":"25","author":"AJM Hennis","year":"2002","unstructured":"Hennis AJM, Fraser HS, White S, et al. Prevalence of diabetes among Afro-Caribbean adults: results from a population-based survey in Barbados. Diabetes Care. 2002;25(7):1191\u20136. https:\/\/doi.org\/10.2337\/diacare.25.7.1191.","journal-title":"Diabetes Care"},{"issue":"10","key":"2015_CR37","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1046\/j.1464-5491.1999.00143.x","volume":"16","author":"RJ Wilks","year":"1999","unstructured":"Wilks RJ, Rotimi CN, Bennett FI, McFarlane-Anderson N, Kaufman JS, Anderson SG, et al. Diabetes in the caribbean: results of a population survey from Spanish Town, Jamaica. Diabet Med. 1999;16(10):875\u201383. https:\/\/doi.org\/10.1046\/j.1464-5491.1999.00143.x.","journal-title":"Diabet Med"},{"issue":"2","key":"2015_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1136\/jech.50.2.123","volume":"50","author":"MC Gulliford","year":"1996","unstructured":"Gulliford MC, Mahabir D, Rocke B. Diabetes-related morbidity in a Caribbean island: the St James Survey, Trinidad. J Epidemiol Community Health. 1996;50(2):123\u20138. https:\/\/doi.org\/10.1136\/jech.50.2.123.","journal-title":"J Epidemiol Community Health"},{"issue":"9131","key":"2015_CR39","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837\u201353. https:\/\/doi.org\/10.1016\/S0140-6736(98)07019-6.","journal-title":"Lancet"},{"key":"2015_CR40","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fphys.2019.00320","volume":"10","author":"S Carlsson","year":"2019","unstructured":"Carlsson S. Latent autoimmune diabetes in adults (LADA): A hybrid form of diabetes. Front Physiol. 2019;10:320. https:\/\/doi.org\/10.3389\/fphys.2019.00320.","journal-title":"Front Physiol"},{"issue":"2","key":"2015_CR41","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2337\/dc08-1296","volume":"32","author":"CC Cowie","year":"2009","unstructured":"Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988\u20131994 and 2005\u20132006. Diabetes Care. 2009;32(2):287\u201394. https:\/\/doi.org\/10.2337\/dc08-1296.","journal-title":"Diabetes Care"},{"issue":"4","key":"2015_CR42","doi-asserted-by":"publisher","first-page":"613","DOI":"10.4239\/wjd.v6.i4.613","volume":"6","author":"AM George","year":"2015","unstructured":"George AM, Jacob AG, Fogelfeld L. Lean diabetes mellitus: an emerging entity in the era of obesity. World J Diabetes. 2015;6(4):613\u201320. https:\/\/doi.org\/10.4239\/wjd.v6.i4.613.","journal-title":"World J Diabetes"},{"issue":"5","key":"2015_CR43","doi-asserted-by":"publisher","first-page":"e01715","DOI":"10.1016\/j.heliyon.2019.e01715","volume":"5","author":"Y Hosokawa","year":"2019","unstructured":"Hosokawa Y, Kozawa J, Nishizawa H, Kawamori D, Maeda N, Otsuki M, Matsuoka TA, Iwahashi H, Shimomura I. Positive correlation between fasting plasma glucagon and serum C-peptide in Japanese patients with diabetes. Heliyon. 2019;5(5):e01715. PMID: 31193194; PMCID: PMC6520599.","journal-title":"Heliyon"},{"issue":"1","key":"2015_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010658","volume":"24","author":"T Salvatore","year":"2022","unstructured":"Salvatore T, Galiero R, Caturano A, Rinaldi L, Criscuolo L, Di Martino A, et al. Current knowledge on the pathophysiology of lean\/normal-weight type 2 diabetes. Int J Mol Sci. 2022;24(1):658. https:\/\/doi.org\/10.3390\/ijms24010658.","journal-title":"Int J Mol Sci"},{"key":"2015_CR45","doi-asserted-by":"publisher","first-page":"107819","DOI":"10.1016\/j.diabres.2019.107819","volume":"155","author":"Consultation on Nutritional Guidelines for the Management of Asian Populations","year":"2019","unstructured":"Consultation on Nutritional Guidelines for the Management of Asian Populations. BMI cut-offs to define overweight and obesity in Asians differ from those in Europeans. Diabetes Res Clin Pract. 2019;155:107819. https:\/\/doi.org\/10.1016\/j.diabres.2019.107819.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"2015_CR46","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.2337\/dc11-1843","volume":"35","author":"K Kodama","year":"2012","unstructured":"Kodama K, Horikawa C, Fujihara K, Heianza Y, Hirasawa R, Yachi Y, et al. Ethnic differences in the relationship between BMI and diabetes incidence: a meta-analysis. Diabetes Care. 2012;35(6):1753\u201360. https:\/\/doi.org\/10.2337\/dc11-1843.","journal-title":"Diabetes Care"},{"issue":"11","key":"2015_CR47","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/sj.ijo.0801053","volume":"23","author":"BA Swinburn","year":"1999","unstructured":"Swinburn BA, Ley SJ, Carmichael HE, Plank LD. Body size and composition in Polynesians. Int J Obes. 1999;23(11):1178\u201383. https:\/\/doi.org\/10.1038\/sj.ijo.0801053.","journal-title":"Int J Obes"},{"key":"2015_CR48","volume-title":"IDF Diabetes Atlas, 10th edition","author":"International Diabetes Federation","year":"2023","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 10th edition. Brussels: International Diabetes Federation; 2023."},{"issue":"10","key":"2015_CR49","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","volume":"126","author":"JP Despr\u00e9s","year":"2012","unstructured":"Despr\u00e9s JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126(10):1301\u201313. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.067264.","journal-title":"Circulation"},{"issue":"11","key":"2015_CR50","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1038\/oby.2007.334","volume":"15","author":"SA Lear","year":"2007","unstructured":"Lear SA, Humphries KH, Kohli S, Birmingham CL. The use of BMI and waist circumference as surrogates of body fat differs by ethnicity. Obesity. 2007;15(11):2817\u201324. https:\/\/doi.org\/10.1038\/oby.2007.334.","journal-title":"Obesity"},{"issue":"8","key":"2015_CR51","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1093\/ajcn\/34.8.1617","volume":"34","author":"NB Ruderman","year":"1981","unstructured":"Ruderman NB, Schneider SH, Berchtold P. The metabolically-obese, normal-weight individual. Am J Clin Nutr. 1981;34(8):1617\u201321. https:\/\/doi.org\/10.1093\/ajcn\/34.8.1617.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"2015_CR52","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.cmet.2017.07.008","volume":"26","author":"N Stefan","year":"2017","unstructured":"Stefan N, Schick F, H\u00e4ring HU. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans. Cell Metab. 2017;26(2):292\u2013300. https:\/\/doi.org\/10.1016\/j.cmet.2017.07.008.","journal-title":"Cell Metab"},{"issue":"2","key":"2015_CR53","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S2213-8587(24)00338-7","volume":"13","author":"N Stefan","year":"2025","unstructured":"Stefan N, Yki-J\u00e4rvinen H, Neuschwander-Tetri BA. Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment. Lancet Diabetes Endocrinol. 2025;13(2):134\u201348. https:\/\/doi.org\/10.1016\/S2213-8587(24)00338-7.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2015_CR54","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","volume":"35","author":"N Stefan","year":"2023","unstructured":"Stefan N, Schick F, Birkenfeld AL, H\u00e4ring HU, White MF. The role of hepatokines in NAFLD. Cell Metab. 2023;35(2):236\u201352. https:\/\/doi.org\/10.1016\/j.cmet.2023.01.006.","journal-title":"Cell Metab"},{"issue":"12","key":"2015_CR55","doi-asserted-by":"publisher","first-page":"770","DOI":"10.7326\/0003-4819-152-12-201006150-00004","volume":"152","author":"DC Ziemer","year":"2010","unstructured":"Ziemer DC, Kolm P, Weintraub WS, Vaccarino V, Rhee MK, Twombly JG, et al. Glucose-independent, black-white differences in hemoglobin A1c levels. Ann Intern Med. 2010;152(12):770\u20137. https:\/\/doi.org\/10.7326\/0003-4819-152-12-201006150-00004.","journal-title":"Ann Intern Med"},{"issue":"3","key":"2015_CR56","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00125-004-1334-6","volume":"47","author":"T Nakagami","year":"2004","unstructured":"Nakagami T. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia. 2004;47(3):385\u201394. https:\/\/doi.org\/10.1007\/s00125-004-1334-6.","journal-title":"Diabetologia"},{"issue":"2","key":"2015_CR57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.beem.2011.09.004","volume":"26","author":"JL Vassy","year":"2012","unstructured":"Vassy JL, Meigs JB. Is genetic testing useful to predict type 2 diabetes? Best Pract Res Clin Endocrinol Metab. 2012;26(2):189\u2013201. https:\/\/doi.org\/10.1016\/j.beem.2011.09.004.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2015_CR58","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.csbj.2016.12.005","volume":"15","author":"I Kavakiotis","year":"2017","unstructured":"Kavakiotis I, Tsave O, Salifoglou A, Maglaveras N, Vlahavas I, Chouvarda I. Machine learning and data mining methods in diabetes research. Comput Struct Biotechnol J. 2017;15:104\u201316. https:\/\/doi.org\/10.1016\/j.csbj.2016.12.005.","journal-title":"Comput Struct Biotechnol J"},{"issue":"7","key":"2015_CR59","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/dme.12159","volume":"30","author":"AG Jones","year":"2013","unstructured":"Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med. 2013;30(7):803\u201317. https:\/\/doi.org\/10.1111\/dme.12159.","journal-title":"Diabet Med"},{"issue":"6","key":"2015_CR60","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487\u201395. https:\/\/doi.org\/10.2337\/diacare.27.6.1487.","journal-title":"Diabetes Care"},{"issue":"3","key":"2015_CR61","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1177\/193229681100500333","volume":"5","author":"A Pf\u00fctzner","year":"2011","unstructured":"Pf\u00fctzner A, Forst T. Elevated intact proinsulin levels are indicative of Beta-cell dysfunction, insulin resistance, and cardiovascular risk: impact of the antidiabetic agent Pioglitazone. J Diabetes Sci Technol. 2011;5(3):784\u201393. PMID: 21722594; PMCID: PMC3192645.","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"2015_CR62","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2337\/db09-9028","volume":"58","author":"RA DeFronzo","year":"2009","unstructured":"DeFronzo RA. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773\u201395. https:\/\/doi.org\/10.2337\/db09-9028.","journal-title":"Diabetes"},{"issue":"10","key":"2015_CR63","doi-asserted-by":"publisher","first-page":"e6171","DOI":"10.7759\/cureus.6171","volume":"11","author":"A Jaiswal","year":"2019","unstructured":"Jaiswal A, Vijayaraghavan R, Nair S. The pathophysiology of type 2 diabetes mellitus in non-obese individuals: an overview of the current Understanding. Cureus. 2019;11(10):e6171. https:\/\/doi.org\/10.7759\/cureus.6171.","journal-title":"Cureus"},{"issue":"12","key":"2015_CR64","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1001\/jamainternmed.2017.6040","volume":"177","author":"JS Haw","year":"2017","unstructured":"Haw JS, Galaviz KI, Straus AN, Kowalski AJ, Magee MJ, Weber MB, Wei J, Narayan KMV, Ali MK. Long-term sustainability of diabetes prevention approaches: A systematic review and Meta-analysis of randomized clinical trials. JAMA Intern Med. 2017;177(12):1808\u201317. PMID: 29114778; PMCID: PMC5820728.","journal-title":"JAMA Intern Med"},{"issue":"8","key":"2015_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008222","volume":"5","author":"K Esposito","year":"2015","unstructured":"Esposito K, Maiorino MI, Bellastella G, Chiodini P, Panagiotakos D, Giugliano D. A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses. BMJ Open. 2015;5(8):e008222. https:\/\/doi.org\/10.1136\/bmjopen-2015-008222.","journal-title":"BMJ Open"},{"issue":"23","key":"2015_CR66","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1001\/jama.2008.808","volume":"300","author":"DJ Jenkins","year":"2008","unstructured":"Jenkins DJ, Kendall CW, McKeown-Eyssen G, Josse RG, Silverberg J, Booth GL, et al. Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA. 2008;300(23):2742\u201353. https:\/\/doi.org\/10.1001\/jama.2008.808.","journal-title":"JAMA"},{"issue":"6","key":"2015_CR67","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","volume":"20","author":"M Foretz","year":"2014","unstructured":"Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: from mechanisms of action to therapies. Cell Metab. 2014;20(6):953\u201366. https:\/\/doi.org\/10.1016\/j.cmet.2014.09.018.","journal-title":"Cell Metab"},{"issue":"3","key":"2015_CR68","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s13300-017-0265-4","volume":"8","author":"E Leighton","year":"2017","unstructured":"Leighton E, Sainsbury CA, Jones GC. A practical review of C-peptide testing in diabetes. Diabetes Ther. 2017;8(3):475\u201387. https:\/\/doi.org\/10.1007\/s13300-017-0265-4.","journal-title":"Diabetes Ther"},{"issue":"1","key":"2015_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-023-01085-y","volume":"15","author":"X Wang","year":"2023","unstructured":"Wang X, Wu N, Sun C, Jin D, Lu H. Effects of SGLT-2 inhibitors on adipose tissue distribution in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Diabetol Metab Syndr. 2023;15(1):113. https:\/\/doi.org\/10.1186\/s13098-023-01085-y.","journal-title":"Diabetol Metab Syndr"},{"issue":"11","key":"2015_CR70","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1007\/s00125-005-1960-7","volume":"48","author":"S Fourlanos","year":"2005","unstructured":"Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, et al. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia. 2005;48(11):2206\u201312. https:\/\/doi.org\/10.1007\/s00125-005-1960-7.","journal-title":"Diabetologia"},{"key":"2015_CR71","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2508.11063","author":"L Remedios","year":"2025","unstructured":"Remedios L, Cho C, Schwartz T, Su D, Rudravaram G, Gao C, et al. Data-Driven abdominal phenotypes of type 2 diabetes in Lean, Overweight, and obese cohorts. ArXiv Preprint. 2025. https:\/\/doi.org\/10.48550\/arXiv.2508.11063.","journal-title":"ArXiv Preprint"},{"issue":"1","key":"2015_CR72","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/joim.12859","volume":"285","author":"RB Prasad","year":"2019","unstructured":"Prasad RB, Groop L. Precision medicine in type 2 diabetes. J Intern Med. 2019;285(1):40\u20138. https:\/\/doi.org\/10.1111\/joim.12859.","journal-title":"J Intern Med"},{"issue":"7","key":"2015_CR73","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2337\/dci20-0022","volume":"43","author":"WK Chung","year":"2020","unstructured":"Chung WK, Erion K, Florez JC, et al. Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2020;43(7):1617\u201335. https:\/\/doi.org\/10.2337\/dci20-0022.","journal-title":"Diabetes Care"},{"issue":"6","key":"2015_CR74","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1001\/jama.2012.9282","volume":"308","author":"MR Carnethon","year":"2012","unstructured":"Carnethon MR, De Chavez PJ, Biggs ML, et al. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308(6):581\u201390. https:\/\/doi.org\/10.1001\/jama.2012.9282.","journal-title":"JAMA"},{"issue":"3","key":"2015_CR75","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1304501","volume":"370","author":"DK Tobias","year":"2014","unstructured":"Tobias DK, Pan A, Jackson CL, et al. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med. 2014;370(3):233\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1304501.","journal-title":"N Engl J Med"},{"issue":"3","key":"2015_CR76","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/jcm3030923","volume":"3","author":"Y Saisho","year":"2014","unstructured":"Saisho Y. Importance of Beta Cell Function for the Treatment of Type 2 Diabetes. J Clin Med. 2014;3(3):923\u201343. https:\/\/doi.org\/10.3390\/jcm3030923.","journal-title":"J Clin Med"},{"issue":"4","key":"2015_CR77","doi-asserted-by":"publisher","first-page":"613","DOI":"10.4239\/wjd.v6.i4.613","volume":"6","author":"AM George","year":"2015","unstructured":"George AM, Jacob AG, Fogelfeld L. Lean diabetes mellitus: an emerging entity in the era of obesity. World J Diabetes. 2015;6(4):613\u201325. https:\/\/doi.org\/10.4239\/wjd.v6.i4.613.","journal-title":"World J Diabetes"},{"key":"2015_CR78","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.diabres.2019.01.004","volume":"148","author":"R Nishimura","year":"2019","unstructured":"Nishimura R, Kanda A, Sano H, et al. Glycemic control and insulin therapy in lean versus obese patients with type 2 diabetes: a 10-year cohort study. Diabetes Res Clin Pract. 2019;148:180\u20137. https:\/\/doi.org\/10.1016\/j.diabres.2019.01.004.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"2015_CR79","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1603827.","journal-title":"N Engl J Med"},{"issue":"7","key":"2015_CR80","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","volume":"377","author":"B Neal","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377(7):644\u201357. https:\/\/doi.org\/10.1056\/NEJMoa1611925.","journal-title":"N Engl J Med"},{"issue":"4","key":"2015_CR81","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa1812389","volume":"380","author":"SD Wiviott","year":"2019","unstructured":"Wiviott SD, Raz I, Bonaca MP, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2019;380(4):347\u201357. https:\/\/doi.org\/10.1056\/NEJMoa1812389.","journal-title":"N Engl J Med"},{"issue":"11","key":"2015_CR82","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.2337\/dc15-0760","volume":"38","author":"NH Kim","year":"2015","unstructured":"Kim NH, Lee J, Kim TJ, et al. Body mass index and mortality in Asian patients with type 2 diabetes: pooled analysis of 18 prospective cohorts. Diabetes Care. 2015;38(11):1967\u201376. https:\/\/doi.org\/10.2337\/dc15-0760.","journal-title":"Diabetes Care"},{"issue":"1\u20132","key":"2015_CR83","first-page":"1","volume":"22","author":"V Mohan","year":"2009","unstructured":"Mohan V, Pradeepa R. Epidemiology of diabetes in different regions of India. Health Administrator. 2009;22(1\u20132):1\u201318.","journal-title":"Health Administrator"},{"issue":"1","key":"2015_CR84","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00125-015-3754-6","volume":"59","author":"ES Huang","year":"2016","unstructured":"Huang ES, Jr H-YL, Liu J, Jin S, Brown CLH, Meltzer DO, et al. Resource use associated with type 2 diabetes in Africa, the middle East, South Asia, Eurasia and turkey: results from the international diabetes management practice study (IDMPS). Diabetologia. 2016;59(1):234\u201342. https:\/\/doi.org\/10.1007\/s00125-015-3754-6.","journal-title":"Diabetologia"},{"issue":"5","key":"2015_CR85","doi-asserted-by":"publisher","first-page":"970","DOI":"10.2337\/diacare.29.05.06.dc05-2101","volume":"29","author":"S Fourlanos","year":"2006","unstructured":"Fourlanos S, Perry C, Stein MS, et al. A clinical screening tool identifies autoimmune diabetes in adults. Diabetes Care. 2006;29(5):970\u20135. https:\/\/doi.org\/10.2337\/diacare.29.05.06.dc05-2101.","journal-title":"Diabetes Care"},{"issue":"8","key":"2015_CR86","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00125-022-05669-6","volume":"65","author":"J Liu","year":"2022","unstructured":"Liu J, Bai R, Chai Z, Cooper ME, Zimmet PZ, Zhang L. Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on global burden of disease 1990\u20132019 data. Diabetologia. 2022;65(8):1339\u201352. https:\/\/doi.org\/10.1007\/s00125-022-05669-6.","journal-title":"Diabetologia"},{"issue":"11","key":"2015_CR87","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1007\/s11606-023-08299-4","volume":"38","author":"Screening for Prediabetes and Diabetes","year":"2023","unstructured":"Screening for Prediabetes and Diabetes. Clinical performance and implications for health equity. J Gen Intern Med. 2023;38(11):2973\u201380. https:\/\/doi.org\/10.1007\/s11606-023-08299-4.","journal-title":"J Gen Intern Med"},{"issue":"8","key":"2015_CR88","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.2337\/dc10-2300","volume":"34","author":"M Chiu","year":"2011","unstructured":"Chiu M, Austin PC, Manuel DG, et al. Deriving ethnic-specific BMI cutoffs for assessing diabetes risk. Diabetes Care. 2011;34(8):1741\u20138. https:\/\/doi.org\/10.2337\/dc10-2300.","journal-title":"Diabetes Care"},{"issue":"10267","key":"2015_CR89","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","volume":"396","author":"JCN Chan","year":"2021","unstructured":"Chan JCN, Lim LL, Wareham NJ, Shaw JE, Orchard TJ, Zhang P, et al. The lancet commission on diabetes: using data to transform diabetes care and patient lives. Lancet. 2021;396(10267):2019\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(20)32374-6.","journal-title":"Lancet"},{"issue":"6","key":"2015_CR90","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S2213-8587(23)00086-4","volume":"11","author":"N Stefan","year":"2023","unstructured":"Stefan N, Schulze MB. Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment. Lancet Diabetes Endocrinol. 2023;11(6):426\u201340. https:\/\/doi.org\/10.1016\/S2213-8587(23)00086-4.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2015_CR91","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s12020-024-04027-5","volume":"67","author":"Early-onset","year":"2024","unstructured":"Early-onset. Type 2 diabetes mellitus: an update. Endocrine. 2024;67(3):505\u201315. https:\/\/doi.org\/10.1007\/s12020-024-04027-5.","journal-title":"Endocrine"},{"issue":"4","key":"2015_CR92","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2337\/ds15-0047","volume":"29","author":"KS O\u2019Neal","year":"2016","unstructured":"O\u2019Neal KS, Johnson JL, Panak RL. Recognizing and appropriately treating latent autoimmune diabetes in adults. Diabetes Spectr. 2016;29(4):249\u201352. https:\/\/doi.org\/10.2337\/ds15-0047.","journal-title":"Diabetes Spectr"},{"issue":"11","key":"2015_CR93","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1111\/dme.13142","volume":"33","author":"SV Hope","year":"2016","unstructured":"Hope SV, Knight BA, Shields BM, McDonald TJ, Hattersley AT, Jones AG. Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic. Diabet Med. 2016;33(11):1554\u20138. https:\/\/doi.org\/10.1111\/dme.13142.","journal-title":"Diabet Med"},{"issue":"1","key":"2015_CR94","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","volume":"62","author":"JL Harding","year":"2019","unstructured":"Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3\u201316. https:\/\/doi.org\/10.1007\/s00125-018-4711-2.","journal-title":"Diabetologia"},{"issue":"Suppl1","key":"2015_CR95","doi-asserted-by":"publisher","first-page":"S316","DOI":"10.4103\/2230-8210.119608","volume":"17","author":"P Chaudhary","year":"2013","unstructured":"Chaudhary P, Laloo D, Salam R. Prevalence of lean type 2 diabetes mellitus in recently diagnosed type 2 diabetes mellitus patients. Indian J Endocrinol Metab. 2013;17(Suppl1):S316\u20137. https:\/\/doi.org\/10.4103\/2230-8210.119608.","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"2015_CR96","first-page":"1","volume":"1","author":"J Skinner","year":"2025","unstructured":"Skinner J, et al. Improving the prevention and treatment of lean type 2 diabetes in sub-Saharan africa: A review. Ethiop J Sci Dev Res. 2025;1(1):1\u201310.","journal-title":"Ethiop J Sci Dev Res"},{"key":"2015_CR97","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/dc12-1805","volume":"36","author":"R Taylor","year":"2013","unstructured":"Taylor R. Type 2 diabetes: etiology and reversibility. Diabetes Care. 2013;36:1047\u201355. https:\/\/doi.org\/10.2337\/dc12-1805.","journal-title":"Diabetes Care"},{"issue":"1","key":"2015_CR98","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/ijms24010658","volume":"24","author":"T Salvatore","year":"2023","unstructured":"Salvatore T, Galiero R, Masullo M, Macchia PE, Morisco C, Sardu C, et al. Lean type 2 diabetes: pathophysiology, clinical features, and management. Int J Mol Sci. 2023;24(1):658. https:\/\/doi.org\/10.3390\/ijms24010658.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2015_CR99","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.3390\/nu5072708","volume":"5","author":"A Misra","year":"2013","unstructured":"Misra A, Shrivastava U. Obesity and dyslipidemia in South Asians. Nutrients. 2013;5(7):2708\u201333. https:\/\/doi.org\/10.3390\/nu5072708.","journal-title":"Nutrients"},{"key":"2015_CR100","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/ijo.2009.68","volume":"33","author":"SA Lear","year":"2009","unstructured":"Lear SA, Humphries KH, Kohli S, Birmingham CL. Ethnic-specific criteria for classification of body mass index: A perspective on South Asians. Int J Obes (Lond). 2009;33:781\u20136. https:\/\/doi.org\/10.1038\/ijo.2009.68.","journal-title":"Int J Obes (Lond)"},{"issue":"11","key":"2015_CR101","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2015-2553","volume":"100","author":"KS Kim","year":"2015","unstructured":"Kim KS, Kim SK, Lee YK, et al. Mortality and cardiovascular risk in lean and obese type 2 diabetes: a nationwide cohort study. J Clin Endocrinol Metab. 2015;100(11):4237\u201345. https:\/\/doi.org\/10.1210\/jc.2015-2553.","journal-title":"J Clin Endocrinol Metab"},{"key":"2015_CR102","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1186\/s12889-024-18509-y","volume":"24","author":"S Lim","year":"2024","unstructured":"Lim S, Kim KM, Choi SH, Kang SM, Park YJ, Jang HC, et al. Increasing prevalence of lean type 2 diabetes in Korean adults: a population-based study. BMC Public Health. 2024;24:1034. https:\/\/doi.org\/10.1186\/s12889-024-18509-y.","journal-title":"BMC Public Health"},{"key":"2015_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.820750","volume":"10","author":"M Sharma","year":"2022","unstructured":"Sharma M, John R, Afrin S, Zhang X, Wang T, Tian M, et al. Cost-effectiveness of population screening programs for cardiovascular diseases and diabetes in low- and middle-income countries: a systematic review. Front Public Health. 2022;10:820750. https:\/\/doi.org\/10.3389\/fpubh.2022.820750.","journal-title":"Front Public Health"},{"issue":"2","key":"2015_CR104","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","volume":"1","author":"N Stefan","year":"2013","unstructured":"Stefan N, H\u00e4ring HU, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1(2):152\u201362. https:\/\/doi.org\/10.1016\/S2213-8587(13)70062-7.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2015_CR105","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","volume":"25","author":"EJ Topol","year":"2019","unstructured":"Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44\u201356. https:\/\/doi.org\/10.1038\/s41591-018-0300-7.","journal-title":"Nat Med"},{"key":"2015_CR106","doi-asserted-by":"publisher","first-page":"112387","DOI":"10.1016\/j.diabres.2025.112387","volume":"227","author":"TA Viswanathan Mohan","year":"2025","unstructured":"Viswanathan Mohan TA, Pramodkumar M, Deepa R, Pradeepa R, Unnikrishnan P, Routray, et al. Lean diabetes is one end of the spectrum of type 2 diabetes and not a separate entity. Diabetes Res Clin Pract. 2025;227:112387. https:\/\/doi.org\/10.1016\/j.diabres.2025.112387.","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"2015_CR107","doi-asserted-by":"publisher","first-page":"617","DOI":"10.4093\/dmj.2019.0129","volume":"44","author":"W Chung","year":"2020","unstructured":"Chung W, Choi Y, Lee S, et al. Insulin resistance and \u03b2-cell function of lean versus overweight\/obese newly diagnosed type 2 diabetes mellitus patients. Diabetes Metab J. 2020;44(5):617\u201325. https:\/\/doi.org\/10.4093\/dmj.2019.0129.","journal-title":"Diabetes Metab J"},{"issue":"9","key":"2015_CR108","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1007\/s00125-023-05947-5","volume":"66","author":"AGORA Diabetes Collaborative Group","year":"2023","unstructured":"AGORA Diabetes Collaborative Group. Diabetes syndrome-based staging and phenotype-specific care pathways: a practical proposal. Diabetologia. 2023;66(9):1552\u201362. https:\/\/doi.org\/10.1007\/s00125-023-05947-5.","journal-title":"Diabetologia"},{"issue":"5","key":"2015_CR109","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00125-024-06091-8","volume":"67","author":"AP Kengne","year":"2024","unstructured":"Kengne AP, Ramachandran A. Feasibility of prevention of type 2 diabetes in low- and middle-income countries. Diabetologia. 2024;67(5):763\u201372. https:\/\/doi.org\/10.1007\/s00125-024-06091-8.","journal-title":"Diabetologia"},{"issue":"1","key":"2015_CR110","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2337\/cd21-0084","volume":"40","author":"R Puhl","year":"2022","unstructured":"Puhl R, Himmelstein MS, Speight J. Weight stigma and diabetes stigma: implications for weight-related health behaviors in adults with type 2 diabetes. Clin Diabetes. 2022;40(1):51\u201361. https:\/\/doi.org\/10.2337\/cd21-0084.","journal-title":"Clin Diabetes"},{"key":"2015_CR111","doi-asserted-by":"publisher","first-page":"110858","DOI":"10.1016\/j.diabres.2024.110858","volume":"197","author":"JF Yamamoto","year":"2024","unstructured":"Yamamoto JF, Goodman PJ. Epidemiology of type 2 diabetes in Caribbean and Pacific Islander populations: genetic predisposition and environmental influences. Diabetes Res Clin Pract. 2024;197:110858. https:\/\/doi.org\/10.1016\/j.diabres.2024.110858.","journal-title":"Diabetes Res Clin Pract"},{"key":"2015_CR112","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s44258-025-00039-5","volume":"22","author":"M Papua","year":"2025","unstructured":"Papua M, et al. Prevalence of diabetes and prediabetes in South Asian countries: a systematic review and meta-analysis. Discover Public Health. 2025;22:39. https:\/\/doi.org\/10.1186\/s44258-025-00039-5.","journal-title":"Discover Public Health"},{"key":"2015_CR113","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S2213-8587(23)00264-9","volume":"11","author":"CJ Nolan","year":"2023","unstructured":"Nolan CJ, Peyrot M, Zehle MR, et al. Interventions to address global inequity in diabetes: international progress. Lancet Diabetes Endocrinol. 2023;11:842\u201356. https:\/\/doi.org\/10.1016\/S2213-8587(23)00264-9.","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Diabetology & Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-02015-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-02015-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-02015-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T14:38:48Z","timestamp":1764167928000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-02015-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2015"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-02015-w","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This review article does not involve human or animal subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This work utilized AI (Claude 4) assistance for language enhancement and editing. The author reviewed all content and accepts full responsibility for the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI assistance declaration"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration number"}}],"article-number":"440"}}